ruxolitinib

BCR activator of RhoGEF and GTPase ; Homo sapiens







1 Article(s)
Download
PMID
Title
Pub. Year
#Total Relationships
1 30956968 Coexistence of BCR/ABL1-positive chronic myeloid leukemia and JAK2 V617F-mutated myelofibrosis successfully treated with dasatinib and ruxolitinib. 2019 Mar 1